L. Braun-Parvez

39th ESCP European symposium on clinical pharmacy & 13th SFPC congress: clinical pharmacy at the front line of innovations. 21–23 October 2010, Lyon, France

C. D. Fajardo, M. P. Ortega, J. C. Barrera, 2011, International Journal of Clinical Pharmacy.

Risk Factors for BK Virus Infection in the Era of Therapeutic Drug Monitoring

L. Braun-Parvez, B. Moulin, S. Caillard, 2013, Transplantation.

Tixagevimab-cilgavimab as an Early Treatment for COVID-19 in Kidney Transplant Recipients

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2022, medRxiv.

Breakthrough COVID-19 cases despite prophylaxis with 150 mg of tixagevimab and 150 mg of cilgavimab in kidney transplant recipients

L. Braun-Parvez, S. Fafi-Kremer, O. Thaunat, 2022, American Journal of Transplantation.

Chronic Lymphocytic Leukemia: A Hazardous Condition Before Kidney Transplantation

L. Braun-Parvez, E. Rondeau, J. Dantal, 2008, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Weak anti–SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2021, Kidney International.

Gestational Choriocarcinoma Transmission Following Multiorgan Donation

J. Bergerat, L. Braun-Parvez, B. Moulin, 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Low immunization rates among kidney transplant recipients who received 2 doses of the mRNA-1273 SARS-CoV-2 vaccine

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2021, Kidney International.

Prediction of Vaccine Response and Development of a Personalized Anti-SARS-CoV-2 Vaccination Strategy in Kidney Transplant Recipients: Results from a Large Single-Center Study

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2022, Journal of personalized medicine.

Strong antibody response after a first dose of a SARS-CoV-2 mRNA-based vaccine in kidney transplant recipients with a previous history of COVID-19

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2021, American Journal of Transplantation.

A rapid decline in the anti–receptor-binding domain of the SARS-CoV-2 spike protein IgG titer in kidney transplant recipients after tixagevimab–cilgavimab administration

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2022, Kidney International.

Atypical hemolytic and uremic syndrome due to C3 mutation in pancreatic islet transplantation: a case report

L. Braun-Parvez, T. Bahougne, L. Kessler, 2020, BMC Nephrology.

Weak anti-SARS-CoV-2 antibody response after the first injection of an mRNA COVID-19 vaccine in kidney transplant recipients

L. Braun-Parvez, S. Fafi-Kremer, B. Moulin, 2021, medRxiv.